IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 213 filers reported holding IMMUNOMEDICS INC in Q4 2018. The put-call ratio across all filers is 1.36 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $3,470,000 | +143.3% | 40,810 | +1.4% | 0.02% | +100.0% |
Q2 2020 | $1,426,000 | +157.4% | 40,250 | -2.0% | 0.01% | +100.0% |
Q1 2020 | $554,000 | -62.6% | 41,071 | -41.3% | 0.00% | -42.9% |
Q4 2019 | $1,480,000 | +47.1% | 69,926 | -7.8% | 0.01% | +16.7% |
Q3 2019 | $1,006,000 | -4.6% | 75,869 | -0.1% | 0.01% | 0.0% |
Q2 2019 | $1,054,000 | -37.7% | 75,979 | -13.7% | 0.01% | -40.0% |
Q1 2019 | $1,692,000 | +39.6% | 88,066 | +3.7% | 0.01% | +25.0% |
Q4 2018 | $1,212,000 | -41.4% | 84,934 | -14.5% | 0.01% | -42.9% |
Q3 2018 | $2,069,000 | -0.3% | 99,310 | +13.3% | 0.01% | 0.0% |
Q2 2018 | $2,076,000 | +58.4% | 87,690 | -2.3% | 0.01% | +55.6% |
Q1 2018 | $1,311,000 | -16.4% | 89,718 | -7.6% | 0.01% | -18.2% |
Q4 2017 | $1,569,000 | +61.1% | 97,075 | +39.3% | 0.01% | +22.2% |
Q3 2017 | $974,000 | +68.2% | 69,704 | +6.3% | 0.01% | +50.0% |
Q2 2017 | $579,000 | +31.9% | 65,590 | -3.3% | 0.01% | +20.0% |
Q1 2017 | $439,000 | +39.8% | 67,831 | -20.8% | 0.01% | +66.7% |
Q4 2016 | $314,000 | +40.2% | 85,638 | +24.1% | 0.00% | 0.0% |
Q3 2016 | $224,000 | +19.1% | 69,028 | -15.0% | 0.00% | +50.0% |
Q2 2016 | $188,000 | -8.3% | 81,246 | -0.8% | 0.00% | -33.3% |
Q1 2016 | $205,000 | -26.0% | 81,936 | -9.1% | 0.00% | 0.0% |
Q4 2015 | $277,000 | +97.9% | 90,152 | +10.8% | 0.00% | +50.0% |
Q3 2015 | $140,000 | -60.3% | 81,372 | -6.3% | 0.00% | -60.0% |
Q2 2015 | $353,000 | +1.1% | 86,852 | -4.8% | 0.01% | +25.0% |
Q1 2015 | $349,000 | -8.4% | 91,218 | +14.9% | 0.00% | 0.0% |
Q4 2014 | $381,000 | +26.6% | 79,406 | -1.7% | 0.00% | 0.0% |
Q3 2014 | $301,000 | -14.5% | 80,796 | -16.2% | 0.00% | -20.0% |
Q2 2014 | $352,000 | -39.4% | 96,399 | -30.1% | 0.01% | -28.6% |
Q1 2014 | $581,000 | +201.0% | 137,993 | +228.9% | 0.01% | +133.3% |
Q4 2013 | $193,000 | -58.7% | 41,951 | -44.4% | 0.00% | -72.7% |
Q3 2013 | $467,000 | +37.0% | 75,451 | +20.3% | 0.01% | +57.1% |
Q2 2013 | $341,000 | – | 62,710 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 1,711,067 | $2,943,000 | 1.70% |
J.P. Turner & Co Capital Mnagement, LLC | 248,625 | $428,000 | 0.44% |
Orbimed Advisors | 3,323,000 | $5,716,000 | 0.06% |
BALYASNY ASSET MANAGEMENT L.P. | 2,004,078 | $3,447,000 | 0.02% |
WOLVERINE ASSET MANAGEMENT LLC | 5,870 | $1,018,000 | 0.02% |
SIGNET FINANCIAL MANAGEMENT, LLC | 44,675 | $77,000 | 0.02% |
SVB WEALTH LLC | 195,000 | $335,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 288,900 | $497,000 | 0.01% |
J.P. Turner & Co Capital Mnagement, LLC | 153,900 | $8,000 | 0.01% |
BALYASNY ASSET MANAGEMENT L.P. | 640,400 | $1,101,000 | 0.01% |